The British Journal of Cardiology

This site is intended for UK healthcare professionals

 
BJC_tv_logo_white
Sign in
Sponsorship statement:
This educational activity was funded by Novartis Pharmaceuticals UK Ltd; however the British Journal of Cardiology retained full editorial control, including the formulation of the agenda, contents, and selection of speakers. The media partners for this activity are the British Journal of Cardiology and GPnotebook.
BJC_logo_red
novartis-logo-transparent

An assessment of new cholesterol targets. Measuring Lp(a): A ‘once in a lifetime’ opportunity

27 November 2025

Sponsored

Dr Julia Kenkre and Dr Holly Morgan explore the role of elevated lipoprotein(a) [Lp(a)] levels in cardiovascular risk, its measurement challenges, clinical implications, and the approach to management.
Key learnings include:

Why Lp(a) is gaining clinical importance, and how elevated Lp(a) levels can influence cardiovascular risk
Best practice for measuring Lp(a) levels including who should be tested and how results can guide management strategies

Podcast

To listen to this webinar, please see the podcast version available here

Categories

Tags

© 2025 Medinews Cardiology Ltd, a wholly-owned subsidiary of OmniaMed Communications Ltd   |   Privacy & cookies policy   |   Terms & conditions

 

Thanks for your feedback. Please note that by including your email address, you are giving permission for us to contact you by email to help resolve any issues.

BJC TV

To continue, please confirm that you are a UK healthcare professional.

I am not a UK healthcare professional
I confirm I am a UK healthcare professional